UniProtKB/Swiss-Prot Q9BY76: Variant p.Arg230Cys

Angiopoietin-related protein 4
Gene: ANGPTL4
Feedback?

Variant information Variant position:

230 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Cysteine (C) at position 230 (R230C, p.Arg230Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Genetic variations in ANGPTL4 are associated with low plasma triglyceride levels and define the plasma triglyceride level quantitative trait locus (TGQTL) [MIM:615881]. Additional information on the polymorphism described.
Other resources:

Links to websites of interest for the variant.

Variant rs201026877 [ dbSNP | Ensembl ]

Sequence information Variant position:

230 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

406 The length of the canonical sequence.
Location on the sequence:

PPFLVNCKMTSDGGWTVIQR R HDGSVDFNRPWEAYKAGFGD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PPFLVNCKMTSDGGWTVIQRRHDGSVDFNRPWEAYKAGFGD

Mouse                         PPFLVNCEMTSDGGWTVIQRRLNGSVDFNQSWEAYKDGFGD

Rat                           PPFLVNCEMTSDGGWTVIQRRLNGSVDFNQSWEAYKDGFGD

Pig                           PPFLVNCKMTSDGGWTVIQRRQDGSVDFNQPWEAYKDGFGD

Bovine                        PPFLVNCKMTSDGGWTVIQRRQDGSVDFNQPWEAYKDGFGD

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	26 – 406	Angiopoietin-related protein 4
Chain	164 – 406	ANGPTL4 C-terminal chain
Domain	179 – 401	Fibrinogen C-terminal
Mutagenesis	223 – 223	G -> R. Impaired protein folding.
Beta strand	222 – 233

Literature citations
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
Romeo S.; Pennacchio L.A.; Fu Y.; Boerwinkle E.; Tybjaerg-Hansen A.; Hobbs H.H.; Cohen J.C.;
Nat. Genet. 39:513-516(2007)
Cited for: ASSOCIATION WITH TGQTL; VARIANTS LEU-5; LYS-40; ILE-41; ARG-67; LEU-72; ARG-77; LYS-167; SER-174; GLN-190; LYS-196; CYS-230; ARG-233; VAL-237; THR-251; MET-266; GLN-278; MET-291; MET-293; VAL-296; SER-307; MET-308; CYS-336; GLU-338; CYS-349; SER-361; ARG-361; GLN-371 AND TRP-384;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.